From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design (Q26992345)

1 September 2014

2 references

13 July 2022

22 October 2022

3 references

13 July 2022

22 October 2022

281

1 reference

page(s)

4085-96

1 reference

issue

18

1 reference

From SARS to MERS: 10 years of research on highly pathogenic human coronaviruses

cites work

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Clinical management and infection control of SARS: lessons learned

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

A decade after SARS: strategies for controlling emerging coronaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Public health lessons from severe acute respiratory syndrome a decade later

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Coronavirus as a possible cause of severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

A novel coronavirus associated with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Identification of a novel coronavirus in patients with severe acute respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Coronavirus genomics and bioinformatics analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Identification of a new human coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

A previously undescribed coronavirus associated with respiratory disease in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

The novel human coronaviruses NL63 and HKU1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Bats are natural reservoirs of SARS-like coronaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Ecology, evolution and classification of bat coronaviruses in the aftermath of SARS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Human betacoronavirus 2c EMC/2012-related viruses in bats, Ghana and Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Close relative of human Middle East respiratory syndrome coronavirus in bat, South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

SARS-CoV ORF1b-encoded nonstructural proteins 12-16: replicative enzymes as antiviral targets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Receptor recognition and cross-species infections of SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Structure-based design, synthesis, and biological evaluation of peptidomimetic SARS-CoV 3CLpro inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Structural Basis of Inhibition Specificities of 3C and 3C-like Proteases by Zinc-coordinating and Peptidomimetic Compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

pH-dependent conformational flexibility of the SARS-CoV main proteinase (M(pro)) dimer: molecular dynamics simulations and multiple X-ray structure analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Activation and maturation of SARS-CoV main protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Production of authentic SARS-CoV M(pro) with enhanced activity: application as a novel tag-cleavage endopeptidase for protein overproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Maturation mechanism of severe acute respiratory syndrome (SARS) coronavirus 3C-like proteinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CLpro) from its polyproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Liberation of SARS-CoV main protease from the viral polyprotein: N-terminal autocleavage does not depend on the mature dimerization mode

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Three-dimensional domain swapping as a mechanism to lock the active conformation in a super-active octamer of SARS-CoV main protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Development of Broad-Spectrum Halomethyl Ketone Inhibitors Against Coronavirus Main Protease 3CLpro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

An efficient method for the synthesis of peptide aldehyde libraries employed in the discovery of reversible SARS coronavirus main protease (SARS-CoV Mpro) inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Crystal structures of the main peptidase from the SARS coronavirus inhibited by a substrate-like aza-peptide epoxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Crystal structures reveal an induced-fit binding of a substrate-like Aza-peptide epoxide to SARS coronavirus main peptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Substrate specificity profiling and identification of a new class of inhibitor for the major protease of the SARS coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Design, synthesis and crystallographic analysis of nitrile-based broad-spectrum peptidomimetic inhibitors for coronavirus 3C-like proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Design, synthesis, and evaluation of inhibitors for severe acute respiratory syndrome 3C-like protease based on phthalhydrazide ketones or heteroaromatic esters

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

A mechanistic view of enzyme inhibition and peptide hydrolysis in the active site of the SARS-CoV 3C-like peptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Advances in the development of thrombin inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

3C Protease of Enterovirus 68: Structure-Based Design of Michael Acceptor Inhibitors and Their Broad-Spectrum Antiviral Effects against Picornaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Cinanserin is an inhibitor of the 3C-like proteinase of severe acute respiratory syndrome coronavirus and strongly reduces virus replication in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Identification of novel inhibitors of the SARS coronavirus main protease 3CLpro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Sometimes intermediates. Do the job!

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: Identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Severe acute respiratory syndrome coronavirus papain-like protease ubiquitin-like domain and catalytic domain regulate antagonism of IRF3 and NF-kappaB signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Deubiquitinating and interferon antagonism activities of coronavirus papain-like proteases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Severe acute respiratory syndrome coronavirus papain-like protease: structure of a viral deubiquitinating enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Structural basis for catalysis and ubiquitin recognition by the severe acute respiratory syndrome coronavirus papain-like protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Structural Basis for the Ubiquitin-Linkage Specificity and deISGylating Activity of SARS-CoV Papain-Like Protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors for the severe acute respiratory syndrome-coronavirus papain-like protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Severe Acute Respiratory Syndrome Coronavirus Papain-like Novel Protease Inhibitors: Design, Synthesis, Protein−Ligand X-ray Structure and Biological Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

X-ray Structural and Biological Evaluation of a Series of Potent and Highly Selective Inhibitors of Human Coronavirus Papain-like Proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Genomic characterizations of bat coronaviruses (1A, 1B and HKU8) and evidence for co-infections in Miniopterus bats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Comparative analysis of twelve genomes of three novel group 2c and group 2d coronaviruses reveals unique group and subgroup features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Coexistence of different genotypes in the same bat and serological characterization of Rousettus bat coronavirus HKU9 belonging to a novel Betacoronavirus subgroup

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

The newly emerged SARS-like coronavirus HCoV-EMC also has an "Achilles' heel": current effective inhibitor targeting a 3C-like protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Crystal structure of the papain-like protease of MERS coronavirus reveals unusual, potentially druggable active-site features

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

The VIZIER project: preparedness against pathogenic RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

The VIZIER project: overview; expectations; and achievements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Structure-based antivirals for emerging and neglected RNA viruses: an emerging field for medicinal chemistry in academia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Stable Benzotriazole Esters as Mechanism-Based Inactivators of the Severe Acute Respiratory Syndrome 3CL Protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FFEBS.12936

Discovery of a novel family of SARS-CoV protease inhibitors by virtual screening and 3D-QSAR studies

21 January 2018

1 reference

12 December 2020

Treatment of chronic hepatitis C: current and future

1 reference

12 December 2020

Anticoagulant properties, clinical efficacy and safety of efegatran, a direct thrombin inhibitor, in patients with unstable angina

1 reference

12 December 2020

Design of wide-spectrum inhibitors targeting coronavirus main proteases

1 reference

12 December 2020

Sensitized detection of inhibitory fragments and iterative development of non-peptidic protease inhibitors by dynamic ligation screening

1 reference

12 December 2020

Identifiers

DOI

10.1111/FEBS.12936

1 reference

Consolidated OpenCitations Corpus – April 2017

release_oiatci5eqfgudes25mja4edtsa

5006694

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/oiatci5eqfgudes25mja4edtsa

24 November 2022

mapped directly with Wikidata item

5006694

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

0 references

1 reference